Back to Search
MICHAEL KNOPP, M.D.,PH.D.
M.D.,PH.D.
Contractor
NPI: 1770607301Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
PMID 16763467·Invest Radiol·2006
8-other
3D MR colonography after intravenous administration of the hepatobiliary contrast agent Gd-BOPTA: bile tagging.
PMID 15503381·Eur Radiol·2004
3-trial
Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
PMID 14695387·Radiology·2004
3-trial
Functional magnetic resonance imaging in oncology for diagnosis and therapy monitoring.
PMID 12700286·Mol Cancer Ther·2003
6-review
Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
PMID 12766899·J Magn Reson Imaging·2003
3-trial
Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studies.
PMID 12447005·Invest Radiol·2002
3-trial
Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA.
PMID 19550401·Exp Oncol·2009
8-other
A comprehensive overview of radioguided surgery using gamma detection probe technology.
PMID 19173715·World J Surg Oncol·2009
6-review
Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer.
PMID 19661844·Invest Radiol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1654 UPHAM DRIVE, 657 MEANS HALL
COLUMBUS, OH 43210 - Phone
- (614) 293-9998
Quick Facts
- NPI
- 1770607301
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile